Mutasem Taha

Mutasem Taha

University of Jordan

H-index: 39

Asia-Jordan

About Mutasem Taha

Mutasem Taha, With an exceptional h-index of 39 and a recent h-index of 22 (since 2020), a distinguished researcher at University of Jordan, specializes in the field of Pharmaceutics, Computer-Aided Molecular Design, Medicinal Chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Protein characteristics substantially influence the propensity of activity cliffs among kinase inhibitors

Preparation of novel shell-ionotropically crosslinked micelles based on hexadecylamine and tripolyphosphate for cancer drug delivery

Ligand-based pharmacophore modeling and machine learning for the discovery of potent aurora A kinase inhibitory leads of novel chemotypes

Synthesis and antitumor activity of model cyclopentene-[g]annelated isoindigos

Structure‐Based Approaches for the Prediction of Alzheimer's Disease Inhibitors: Comparative Interactions Analysis, Pharmacophore Modeling and Molecular Dynamics Simulations

Vitamin B12 binding to mutated human transcobalamin, in-silico study of TCN2 alanine scanning and ClinVar missense mutations/SNPs

Synthesis, anticancer evaluation and docking studies of novel adamantanyl-1, 3, 4-oxadiazol hybrid compounds as Aurora-A kinase inhibitors

A Click Synthesis, Molecular Docking and Biological Evaluation of 1, 2, 3-triazoles-benzoxazepine hybrid as potential anticancer agents

Mutasem Taha Information

University

Position

Professor of Drug Design

Citations(all)

4884

Citations(since 2020)

2288

Cited By

3389

hIndex(all)

39

hIndex(since 2020)

22

i10Index(all)

121

i10Index(since 2020)

73

Email

University Profile Page

University of Jordan

Google Scholar

View Google Scholar Profile

Mutasem Taha Skills & Research Interests

Pharmaceutics

Computer-Aided Molecular Design

Medicinal Chemistry

Top articles of Mutasem Taha

Title

Journal

Author(s)

Publication Date

Protein characteristics substantially influence the propensity of activity cliffs among kinase inhibitors

Scientific Reports

Safa Dauod

Mutasem Taha

2024/4/20

Preparation of novel shell-ionotropically crosslinked micelles based on hexadecylamine and tripolyphosphate for cancer drug delivery

Pharmaceutical Development and Technology

Enas Alkhafaji

Isra Dmour

Mohamed K Al-Essa

Walhan Alshaer

Ahmad Aljaberi

...

2024/3/19

Ligand-based pharmacophore modeling and machine learning for the discovery of potent aurora A kinase inhibitory leads of novel chemotypes

Molecular Diversity

Rajaa Banat

Safa Daoud

Mutasem Omar Taha

2024/3/6

Synthesis and antitumor activity of model cyclopentene-[g]annelated isoindigos

Zeitschrift für Naturforschung C

Mustafa M El-Abadelah

Ahmad H Abdullah

Jalal A Zahra

Salim S Sabri

Sanaa K Bardaweel

...

2024/2/29

Structure‐Based Approaches for the Prediction of Alzheimer's Disease Inhibitors: Comparative Interactions Analysis, Pharmacophore Modeling and Molecular Dynamics Simulations

ChemistrySelect

Enfale Zerroug

Salah Belaidi

Samir Chtita

Ghada Tuffaha

Faizan AbulQais

...

2024/2/12

Vitamin B12 binding to mutated human transcobalamin, in-silico study of TCN2 alanine scanning and ClinVar missense mutations/SNPs

Journal of Biomolecular Structure and Dynamics

Omar Abuyaman

Ma’mon M Hatmal

Nawal Hijjawi

Ahmad A Deeb

Mohammad Abuothman

...

2023/5/24

Synthesis, anticancer evaluation and docking studies of novel adamantanyl-1, 3, 4-oxadiazol hybrid compounds as Aurora-A kinase inhibitors

Areej M Jaber

Mohammed M Al-Mahadeen

Raed A Al-Qawasmeh

Mutasem O Taha

2023/11

A Click Synthesis, Molecular Docking and Biological Evaluation of 1, 2, 3-triazoles-benzoxazepine hybrid as potential anticancer agents

Medicinal Chemistry Research

Muhammad Ashram

Almeqdad Y Habashneh

Sanaa Bardaweel

Mutasem O Taha

2023/2

Computational workflow for discovering small molecular binders for shallow binding sites by integrating molecular dynamics simulation, pharmacophore modeling, and machine …

Journal of Computer-Aided Molecular Design

Nour Jamal Jaradat

Mamon Hatmal

Dana Alqudah

Mutasem Omar Taha

2023/8/19

Discovery of new PKN2 inhibitory chemotypes via QSAR-guided selection of docking-based pharmacophores

Molecular Diversity

Mahmoud A Al-Sha’er

Haneen A Basheer

Mutasem O Taha

2023/2

Tableting-induced mechanochemical matrix crosslinking: Towards non-disintegrating chitosan-based sustained delivery tablets

Journal of Drug Delivery Science and Technology

Isra Dmour

Mutasem O. Taha

2023/6/20

Molecular docking, molecular dynamics simulations and in vitro screening reveal cefixime and ceftriaxone as GSK3β covalent inhibitors

RSC advances

Husam Nassar

Wolfgang Sippl

Rana Abu Dahab

Mutasem Taha

2023

Augmenting Bioactivity by Docking‐Generated Multiple Ligand Poses To Enhance Machine Learning and Pharmacophore Modelling: Discovery of New TTK Inhibitors as Case Study

Molecular Informatics

Amenah M Al-Imam

Safa Daoud

Ma’mon M Hatmal

Mutasem Taha

2023/5/25

Discovery of new STAT3 inhibitors as anticancer agents using ligand-receptor contact fingerprints and docking-augmented machine learning

RSC advances

Nour Jamal Jaradat

Walhan Alshaer

Mamon Hatmal

Mutasem Omar Taha

2023

Dipeptidyl Peptidase-IV Blockers Potently Inhibit Monoglyceride Lipase: Investigation By Docking Studies And In Vitro Bioassay

Medicinal Chemistry Research

Dania Alkabbani

Lina A Dahabiyeh

Mutasem O Taha

2023/1

Asenapine as a Potential Lead Inhibitor against Central Ca2+/Calmodulin-Dependent Protein Kinase II: Investigation by Docking Simulation and Experimental Validation

The Open Medicinal Chemistry Journal

Safa Daoud

Reem Abutayeh

Shada Alabed

Mutasem Taha

2023/3/3

Discovery of potent maternal embryonic leucine zipper kinase (MELK) inhibitors of novel chemotypes using structure-based pharmacophores

Medicinal Chemistry Research

Safa Daoud

Shada J Alabed

Sanaa K Bardaweel

Mutasem O Taha

2023/12

Activity Cliffs As Protein-Related Phenomenon: Investigation Using Machine Learning Against Numerous Protein Kinases

Safa Daoud

Mutasem Taha

2022/1/4

Discovery of new potent lysine specific histone demythelase-1 inhibitors (LSD-1) using structure based and ligand based molecular modelling and machine learning

RSC Advances

Shada Alabed

Malik Zihlif

Mutasem Taha

2022/12

Discovery of new Cdc2-like kinase 4 (CLK4) inhibitors via pharmacophore exploration combined with flexible docking-based ligand/receptor contact fingerprints and machine learning

RSC advances

Mai Fayiz Al-Tawil

Safa Daoud

M Hatmal Ma'mon

Mutasem Omar Taha

2022

See List of Professors in Mutasem Taha University(University of Jordan)

Co-Authors

H-index: 39
Fatma U Afifi

Fatma U Afifi

University of Jordan

H-index: 36
Yasser Bustanji

Yasser Bustanji

University of Jordan

H-index: 28
Ahmad Disi

Ahmad Disi

University of Jordan

H-index: 26
Hatim S. AlKhatib

Hatim S. AlKhatib

University of Jordan

H-index: 25
Amal G. Al-Bakri

Amal G. Al-Bakri

University of Jordan

H-index: 24
Mohammad Mohammad

Mohammad Mohammad

University of Jordan

academic-engine